Brightsurf Science News & Current Events

October 13, 2001
New data show Actonel® reduced clinical vertebral fractures in as early as six months
New findings from clinical studies in 2,442 postmenopausal women offer evidence that Actonel® (risedronate sodium tablets) 5 mg reduced clinical vertebral (spinal) fractures as early as six months (p<0.01). Clinical vertebral fractures were reported as adverse events and all were confirmed radiographically.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.